🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Good time to be a Pathologist. Positions abound. #PathTwitter

Join us for #LaboratoryMedicine #GrandRounds "Health Inequities, APOL1, and Chronic Kidney Disease in African Americans and Blacks" with Dr. Young on Wed, Feb 1 at 3:30pm PT. Learn more: buff.ly/3kHyFpo #RenalPath #MedTwitter #MedEd

Let me just... zzz 😴

The Washington State Society of Pathologists (WSSP) Annual Meeting is coming up on 29 April 2023 with a focus on recent changes in #BreastCancer #Pathology and #Oncology at the Women’s University Club of #Seattle tinyurl.com/4ua2wcr9

Well-deserved recognition for the University of Washington Husky Coronavirus Team’s work over the past 3+ years! At multiple, critical points during the #COVID19 #pandemic, this program allowed for critical community testing and preservation of #clinical #lab resources.

High level smoke easily spotted on the visible satellite image at sunrise covering the northern half of the state. #wawx

If you haven’t voted yet please take a moment and select your #MolPath representatives. As genomic medicine gets more complex we need strong advocates for our field leading the field. The future depends on the choices we make 🗳️ Sanam Loghavi, MD صنم لغوی 🔬🧬 Rashmi Kanagal-Shamanna, MD Association for Molecular Pathology

AMP is pleased to present Secretary Xavier Becerra with our Champion for Innovation Award in recognition of his 30-year career in public service, fighting #genepatents and advancing the #Cancer Moonshot Program, AllofUsResearch Program, ARPA-H, and more. ow.ly/cWQ550ON0se #molpath

Ten years back in Annie Mac Presents v. Myriad Genetics the US #supremecourt unanimously invalidated patents on human genes. Take a moment to acknowledge that historic decision and the impact of the ruling on #MolPath #MolDx Thank you AMP for reminding us 🧬

Let’s #AMPlify Yassmine Akkari, PhD Laura J. Tafe, MD Federico Monzon @DNARNADan MoPathGuy Eric Konnick, MD Somak Roy, MD Jonathan A. Nowak Ronald Przygodzki Barbara Zehnbauer Robyn Temple-Smolkin Sid Sen, MD,PhD Rashmi Kanagal-Shamanna, MD Sanam Loghavi, MD صنم لغوی 🔬🧬 Ashley Shean Esther Babady, PhD Association for Molecular Pathology

"The field of #molpath has flourished since 2013," said [Eric Konnick, MD]. This growth "would not be possible if companies, universities, or other institutions held patents that gave them testing monopolies on gene sequences." ow.ly/gzFA50ONy0H #genepatents

Applications for all #AMPath23 Travel Awards are due THIS FRIDAY! Selected individuals will receive reimbursement for travel to Salt Lake City, UT and free meeting registration. Apply now: amp23.amp.org/awards/annual-… #molpath #pathtwitter

Good luck to everyone taking subspecialty exams!

Honored to have been selected to honor the life and work of former World Health Organization (WHO) Director-General Lee Jong-Wook at the the 2nd Annual University of Washington UW Dept. of Laboratory Medicine and Pathology 🔬 Memorial Lecture on 8/9/2023: #LDTs, #IVDs, and FDA: An Unexpected Journey. youtu.be/eiBA15NhsIw

Some thoughts from The Wall Street Journal about the recently unveiled #FDA proposed #rule regarding massive additional regulation on #laboratory Developed #tests (#LDTs). Despite the hype from the Agency, #patients are likely to suffer due to proposed changes. wsj.com/articles/rober…

#Academics and #pathologists have many concerns about the #FDA #ProposedRule to Regulate #LDTs like physical products, rather than #medical services. #Access, #innovation, and #PatientCare may all suffer. Listen to our #podcast discussion here: arup.utah.edu/education/podc…

Cancer drug shortages should not be a political issue. @senatorcantwell Join your colleagues in the House and Senate to swiftly mitigate widespread cancer #drugshortages. Patients’ lives are at stake. #ASCOAdvocacy

#Drugshortages are impacting thousands of individuals w/ cancer, including individuals with cancer in your state @pattymurray. Time is not on our side. Please work with your colleagues to mitigate these shortages. #ASCOAdvocacy

Cancer patients cannot afford to delay treatment due to #drugshortages. @pramilajayapal, please work with your colleagues on both sides of the aisle to address these shortages. #ASCOAdvocacy

"The final rule impacts all laboratory developed testing procedures, regardless of the type, putting the entire field of molecular pathology at risk." — Laurie Menser, CEO of Association for Molecular Pathology, in an interview with The Pathologist about our lawsuit against the FDA thepathologist.com/inside-the-lab…